Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer

Kim JH, Lee YC

  • KMID: 782915
  • Korean J Gastroenterol.
  • 2007 Sep;50(3):207-209.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Phase II Study of Vinorelbine, Mitomycin C and Cisplatin Chemotherapy for Advanced Non-Small Cell Lung Cancer

Kwon MR, Jeong TY, Yuh YJ, Kim SR

  • KMID: 759617
  • Korean J Intern Med.
  • 2002 Dec;17(4):240-244.
BACKGROUND: This prospective phase II trial was performed to determine the efficacy and toxicity of mitomycin C, vinorelbine and cisplatin combination chemotherapy for patients with previously untreated stage IIIB...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen

Chung HC, Roh JK, Park YJ, Lee SI, Min JS, Lee JT, Lee KB, Kim BS

The prognosis of unresectable advanced gastric cancer is extremely poor. We tried a neoadjuvant chemotherapy in locally advanced unresectable stomach cancer diagnosed by initial explo-laparotomy. After chemotherapy with the FADE...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study

Lee SJ, Ahn BM, Kim JG, Sohn SK, Chae YS, Moon JH, Lee EB, Kim JC, Park IK, Jeon SW

We aimed to evaluate the feasibility of concurrent chemoradiotherapy (CRT) with capecitabine and cisplatin in patients with squamous cell carcinoma of the esophagus. Eighteen patients with esophageal cancer were enrolled...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epirubicin, Cisplatin, and Protracted Venous Infusion of 5-Fluorouracil for Advanced Gastric Carcinoma

Cho EK, Lee WK, Lim DY, Bang SM, Park DK, Park YH, Kwon OS, Choi DJ, Shin DB, Lee JH, Lee TH

To evaluate the activity and safety of a combination chemotherapy with epirubicin, cisplatin, and a protracted venous infusion of 5-fluorouracil (ECF) in unresectable or metastatic gastric cancer, a phase II...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ESHAP Salvage Therapy for Relapsed or Refractory Non-Hodgkin's Lymphoma

Choi CW, Paek CW, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS

The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine (ara-C), and cisplatin, has been shown to be active against refractory or relapsed non-Hodgkin's lymphoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma

Scandurra , Scibilia G, Banna GL, D'Agate G, Lipari H, Gieri S, Scollo P

OBJECTIVE: To evaluate the efficacy and tolerability of a neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy in patients with locally advanced cervical carcinoma. METHODS: Patients with histologically confirmed locally advanced cervical carcinoma,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase II Study to Topotecan and Cisplatin in Advanced Hepatocellular Carcinoma

Lee GY, Kim BS, Seo YT, Choi SH, Kim HJ, Choi DS, Ko JY, Yang SH, Byun JH

  • KMID: 1106144
  • Korean J Intern Med.
  • 2003 Jun;18(2):104-108.
BACKGROUND: Hepatocellular carcinoma remains a highly chemoresistant neoplasm and is a common malignancy with poor prognosis in Korea. We performed a phase II study to evaluate the efficacy and toxicities...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer

Kang SH, Kim JI, Goh PG, Hwang SW, Kwon DS, Nam KW, Kang HM, Kang YS, Moon HS, Kim SH, Seong JK, Lee BS, Jeong HY

  • KMID: 782906
  • Korean J Gastroenterol.
  • 2007 Sep;50(3):157-163.
BACKGROUND/AIMS: The purpose of this study was to investigate the efficacy and safety of 'docetaxel-5-FU-cisplatin' combination chemotherapy as a first-line treatment in patients with metastatic or recurrent gastric cancer. ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr